Arbutus Biopharma Corporation (ABUS:NASDAQ) soared at $6.2, a gain of 119.9%. On Wed 22 Jul 20, ABUS:NASDAQ touched a New 2-Week Intraday High of $3.06. The stock appeared on our News Catalysts scanner on Thu 23 Jul 20 at 04:43 PM in the 'BIOTECH' category. From Wed 08 Jul 20, the stock recorded 50.00% Up Days and 54.55% Green Days
The stock spiked on Thu 20 Feb 20 at $3.56 with a volume of 1M+.
About Arbutus Biopharma Corporation (ABUS:NASDAQ)
Arbutus Biopharma Corp is a biopharmaceutical business engaged in advancing novel RNA interference therapeutics and discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection.
Top 10 Gainers:
- Milestone Pharmaceuticals Inc. (MIST:NASDAQ), 166.77%
- Arbutus Biopharma Corporation (ABUS:NASDAQ), 119.86%
- RigNet, Inc. (RNET:NASDAQ), 48.34%
- Brightcove Inc. (BCOV:NASDAQ), 44.24%
- PolyMet Mining Corp. (PLM:NYSEMKT), 35.93%
- Mogo Inc. (MOGO:NASDAQ), 35%
- Lightbridge Corporation (LTBR:NASDAQ), 29.87%
- Helix Energy Solutions Group, Inc. (HLX:NYSE), 26.96%
- Reed's, Inc. (REED:NASDAQ), 25.96%
- CymaBay Therapeutics, Inc. (CBAY:NASDAQ), 25.07%